Braskem S.A. (BAK) has a negative trailing P/E of -0.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -133.12%.
Criteria proven by this page:
Overall SharesGrow Score: 32/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -66.7 | 0.59 | 10.02 | 0.58 | 7.28% |
| 2017 | 8.8 | -0.01 | 5.69 | 0.73 | 2.78% |
| 2018 | 13.2 | -0.51 | 5.56 | 0.65 | 3.97% |
| 2019 | -9.3 | 0.05 | 19.42 | 0.45 | 2.84% |
| 2020 | -2.8 | -0.02 | -43.90 | 0.32 | 0.01% |
| 2021 | 3.3 | -0.01 | 5.94 | 0.44 | 12.82% |
| 2022 | -57.6 | 0.54 | 2.64 | 0.20 | 6.97% |
| 2023 | -3.7 | -0.01 | 4.27 | 0.24 | 0.04% |
| 2024 | -0.8 | -0.01 | -1.99 | 0.12 | 0.06% |
| 2025 | -0.7 | 0.05 | -0.40 | 0.09 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-2.08 | $47.66B | $-411.47M | -0.9% |
| 2017 | $19.40 | $49.26B | $4.08B | 8.3% |
| 2018 | $14.40 | $58B | $2.87B | 4.9% |
| 2019 | $-13.28 | $52.32B | $-2.64B | -5% |
| 2020 | $-35.24 | $58.54B | $-7.02B | -12% |
| 2021 | $70.16 | $105.63B | $13.99B | 13.2% |
| 2022 | $-4.12 | $96.52B | $-820M | -0.8% |
| 2023 | $-11.50 | $70.57B | $-4.58B | -6.5% |
| 2024 | $-28.40 | $77.41B | $-11.32B | -14.6% |
| 2025 | $-24.32 | $69.33B | $-9.69B | -14% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-7.08 | $-7.26 – $-6.87 | $78.77B | $73.03B – $85.05B | 2 |
| 2027 | $-1.79 | $-1.97 – $-1.62 | $84.09B | $77.96B – $90.8B | 1 |
| 2028 | $-8.85 | $-9.77 – $-8.01 | $67.18B | $62.28B – $72.54B | 1 |
| 2029 | $-8.70 | $-9.60 – $-7.87 | $69.16B | $64.12B – $74.68B | 1 |
